title: SET-C versus fluoxetine in the treatment of childhood social phobia.
abstract: OBJECTIVE
  To determine the efficacy of fluoxetine, pill placebo, and Social Effectiveness Therapy for Children (SET-C) for children and adolescents with social phobia.
  
  
  METHODS
  Youths ages 7 to 17 were randomly assigned to one of the treatment conditions. Outcome was evaluated using self-reports, parent ratings, independent evaluator ratings, and behavioral assessment.
  
  
  RESULTS
  Both fluoxetine and SET-C were more efficacious than placebo in reducing social distress and behavioral avoidance and increasing general functioning. SET-C was superior to fluoxetine on each of these measures and was the only treatment superior to placebo in terms of improving social skills, decreasing anxiety in specific social interactions, and enhancing ratings of social competence. Furthermore, whereas fluoxetine appears to exert maximum effect by 8 weeks, SET-C provides continued improvement through week 12.
  
  
  CONCLUSIONS
  Both fluoxetine and SET-C are efficacious for social phobia, although SET-C appears to provide added benefit by enhancing social skills.
authors.affiliation: Department of Psychology, University of Central Florida, Orlando, FL32186, USA. dbeidel@mail.ucf.edu
authors.forename: Deborah C
authors.initials: DC
authors.lastname: Beidel
authors.forename: Samuel M
authors.initials: SM
authors.lastname: Turner
authors.forename: Floyd R
authors.initials: FR
authors.lastname: Sallee
authors.forename: Robert T
authors.initials: RT
authors.lastname: Ammerman
authors.forename: Lori A
authors.initials: LA
authors.lastname: Crosby
authors.forename: Sanjeev
authors.initials: S
authors.lastname: Pathak
mesh_terms: D000293:Adolescent; D002648:Child; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D039721:Diagnostic and Statistical Manual of Mental Disorders; D004334:Drug Administration Schedule; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010698:Phobic Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D012720:Severity of Illness Index
chemical_list: D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors